AWB-17044-69251
4 vaccinations
8 coded responses
21 check-ins
8 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 321 / FL
- Registered
- 2021-12-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Dose 1 — Moderna
-
2021-04-16
Dose 2 — Moderna
-
2021-12-06
Registered in v-safe
-
2021-12-07
Dose 3 — Moderna
-
2021-12-07
Health check-in — day 0, dose 3Feeling: Good · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-08
Survey response — days 1–6 daily, dose 3MedDRA: Injection site erythema, Injection site swelling — Feeling: Poor · Site: Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Some swelling and redness around the injection site.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-09
Survey response — days 1–6 daily, dose 3MedDRA: Arthralgia, Injection site pain, Joint range of motion decreased — Feeling: Fair · Site: Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tirednessFree text: While range of motion was affected yesterday due to pain around injection site, today range of motion seems unaffected. A dull pain persists at top of shoulder.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
-
2022-01-18
Survey response — day 42, dose 3MedDRA: Dermatitis contact, Rash — Feeling: Poor · Be unable to do your normal daily activitiesFree text: I believe I developed a rash/contact dermatitis from poison ivy or poison oak...not COVID related, but can not be sure.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-08
Survey response — 3 months, dose 3MedDRA: Dermatitis contact, Office visit, Rash, Sensitive skin, Urticaria — Feeling: Fair · Be unable to do your normal daily activitiesFree text: I developed a rash and broke out in hives on the arm that received the vaccine. Dermatologist gave a diagnosis of contact dermatitus . A biopsy did not reveal any bacteria or fungus, however, it did show a hypersensitive skin. Unlnown if relatedMedDRA releases: 2024-11 · check-in free text available
- 2022-06-07
-
2022-11-16
Dose 4 — ModernaCo-administered: Flu
-
2022-11-30
Survey response — day 14, dose 4MedDRA: Eczema, Psoriasis, Sensitive skin — Feeling: GoodFree text: I appear to have developed hypersensitive skin and have frequent outbreaks of Eczema/Psoriasis since my first vaccination.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Survey response — day 21, dose 4MedDRA: Cough, Ear infection, Eczema, Pre-existing disease — Feeling: GoodFree text: Eczema outbreaks continue. I have developed an apparent ear infection and a sporadic cough.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Survey response — day 28, dose 4MedDRA: Ear infection, Eczema, Rash — Feeling: GoodFree text: Excema rashes continue. I have also developed an ear infection.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Survey response — day 35, dose 4MedDRA: Eczema, Labyrinthitis, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Eczema has worsened and I have developed a sever inner ear infection in my right ear.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Report sent to call center — day 35, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-22
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-29
- 2023-02-18
- 2023-05-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Moderna | No |
| 2 | 2021-04-16 | Moderna | No |
| 3 | 2021-12-07 | Moderna | No |
| 4 | 2022-11-16 | Moderna | Flu |
Call center
1 call center case
1 successful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Some swelling and redness around the injection site.
Systemic reaction (other): While range of motion was affected yesterday due to pain around injection site, today range of motion seems unaffected. A dull pain persists at top of shoulder.
Release 10 — day 42, dose 3
Symptoms: I believe I developed a rash/contact dermatitis from poison ivy or poison oak...not COVID related, but can not be sure.
Release 11 — 3 months, dose 3
Symptoms: I developed a rash and broke out in hives on the arm that received the vaccine. Dermatologist gave a diagnosis of contact dermatitus . A biopsy did not reveal any bacteria or fungus, however, it did show a hypersensitive skin. Unlnown if related cut off by CDC
Release 12 — day 14, dose 4
Symptoms: I appear to have developed hypersensitive skin and have frequent outbreaks of Eczema/Psoriasis since my first vaccination.
Release 12 — day 21, dose 4
Symptoms: Eczema outbreaks continue. I have developed an apparent ear infection and a sporadic cough.
Release 12 — day 28, dose 4
Symptoms: Excema rashes continue. I have also developed an ear infection.
Release 12 — day 35, dose 4
Symptoms: Eczema has worsened and I have developed a sever inner ear infection in my right ear.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dermatitis contact | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Eczema | · | · | ✓ |
| SD | Labyrinthitis | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Psoriasis | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Sensitive skin | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Joint range of motion decreased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release